Join the club for FREE to access the whole archive and other member benefits.

Rachit Bakshi

Assistant Professor of Neurology, Harvard

Rachit Bakshi, PhD, is an instructor of neurology at Massachusetts General Hospital, Harvard Medical School, Boston. Dr. Bakshi trained as a cell and molecular biologist and later developed expertise in biochemistry and cell biology of Parkinson's disease (PD). In his research, Dr. Bakshi follows genetic and environmental clues as he develops therapeutic targets for neurodegenerative diseases in general and for Parkinson's disease in particular. Dr. Bakshi previously completed post-doctoral training in the laboratory of Clemens Scherzer, MD, at Brigham and Women's Hospital and participated in the collaborative Harvard NeuroDiscovery Center Biomarker Study, where he investigated variants of the alpha-synuclein gene that increase the risk of disease and defects in mitochondria -- cells' energy generators -- in Parkinson's disease.

Dr. Bakshi joined Massachusetts General Hospital as a junior faculty member in 2012. His initial work there in collaboration with Michael Schwarzschild, MD, PhD, focused on characterizing the neuroprotective role and mechanisms of uric acid and activators of Nrf2 pathway in pre-clinical models of PD and other neurodegenerative diseases. He currently studies damaging effects of mutations -- genetic changes -- in the leucine-rich repeat kinase 2 (LRRK2) gene, the greatest known genetic contributor to PD. His research interests also include the identification of potential predictive biomarkers -- objective measures of disease -- and the development of clinical methods of biomarker detection.

Visit website: https://connects.catalyst.harvard.edu/Profiles/profile/1240096

 rachit-bakshi-7b9a3a16

See also

Harvard University

Private Ivy League research university in Massachusetts

Details last updated 18-May-2020

Rachit Bakshi News

Reduced risk of Parkinson's disease for coffee and tea drinkers

Reduced risk of Parkinson's disease for coffee and tea drinkers

Independent - 18-May-2020

Lead study linking caffeine and its disease-slowing potential